Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 704 (USA) (Dr. Tanaka)
· consented 2013-08-27
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-17 (study day 22.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-05 (study day 10.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild MALAISE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-05 (study day 10.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild MALAISE — outcome: RECOVERED/RESOLVED; onset 2013-09-05 (study day 10.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-09-22 (study day 27.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-14 (study day 19.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.